INTRODUCTION
Basal cell carcinoma (BCC) of the vulva is a rare condition, as it represents
less than 0.4% of all BCC cases and 2% to 4% of vulvar neoplasms. It is
estimated that around 6,190 cases occur annually in the world and an increase
of
4.6% in the number of cases is expected every 5 years. The highest prevalence
occurs in white, multiparous, and postmenopausal women, especially in the
seventh decade of life, therefore, advanced age is a risk factor, but it can
also occur in young patients1,2.
Regarding the clinical presentation, the lesions can vary from solitary
pinkish-red papules or plaques on the labia majora to bilateral, multiple
lesions, and in advanced stages, ulceration occurs. Regarding etiology, since
the affected region is located in an area protected from solar radiation, there
is possibly an association with the following factors: chronic inflammation,
exposure to ionizing radiation and arsenic, immunosuppression, pelvic radiation
or trauma; that is, damage that is not related to ultraviolet radiation, but
that can also generate mutations. Therefore, it is important to research
secondary conditions such as lichen sclerosus, nevoid syndrome, and Paget’s
disease, since there are documented cases in the literature of BCC in these
diseases2.
Symptoms are nonspecific and include itching, pain, ulcerations, and bleeding.
These are part of a condition with late and variable clinical presentation and
are therefore factors that can delay diagnosis and treatment. The most common
type is nodular, to the detriment of other rarer variants such as superficial,
infiltrative, and mixed3.
Dermoscopy presents characteristics similar to those of other sites: oval,
bluish-gray nests, arborizing telangiectasias, and leaf-shaped structures with
bright clear areas and ulceration4. Treatment is surgical, but recurrence may
occur because the edges of the tumor are not easily well delineated, making it
difficult to obtain free surgical margins and increasing the chances of
performing incomplete excisions5,6.
OBJECTIVE
The objective of the study was to report a case of BCC of the vulva in which
aspects of diagnosis and treatment were discussed.
CASE REPORT
A 63-year-old woman, G1P1A0, presented to the office in Teresina, PI, in January
2022 for treatment of a persistent lesion on the vulva. She noticed the presence
of the nodule after an ingrown hair persisted while waxing the area. Her history
included systemic arterial hypertension and a total abdominal hysterectomy, with
preservation of the ovaries, performed in 2006 due to symptomatic myoma and
smoking for around 30 years. The gynecological examination revealed a raised
tumor in the upper third of the labia majora on the left, measuring
approximately 1.0x0.8cm, without ulceration and slightly irregular edges, in
addition to the absence of suspected inguinal lymphadenopathy on clinical and
ultrasound examination (Figure 1).
Figure 1 - Injury to the vulva presented by the patient.
Figure 1 - Injury to the vulva presented by the patient.
A transvaginal ultrasound and vulvoscopy were indicated. A small simple cyst on
the left ovary and a hyperchromic lesion with a smooth surface on the left labia
majora were identified, respectively, suspected of neoplasia. The histopathology
of the material from the incisional biopsy of the lesion (Figure 2) showed that it was likely nodular basal cell
carcinoma, with invasion of the dermis and without perineural invasion.
Figure 2 - Histopathology of incisional biopsy (magnification:
100x).
Figure 2 - Histopathology of incisional biopsy (magnification:
100x).
The patient underwent resection of the vulvar tumor with free macroscopic margins
and primary suture. During the surgery, there were no complications and the
patient was discharged one night after the procedure. In the immediate and late
postoperative period, there were no complications, such as dehiscence and/or
inflammation. The histopathology of the surgical specimen (Figure 3) showed a nodular basal cell carcinoma with an
irregular, flat, white area, measuring 0.7x0.4cm, with the lateral margins 7.0
and 5.0mm apart and the deep margins, 5.9mm; all free. The patient, 14 months
after surgery, has no evidence of local or regional recurrence.
Figure 3 - Histopathology of the surgical specimen (magnification:
400x).
Figure 3 - Histopathology of the surgical specimen (magnification:
400x).
The study was approved by the Research Ethics Committee of the State University
of Piauí (CEP- UESPI), Opinion No. 4,311,835/2020. The patient signed the Free
and Informed Consent Form (TCLE) for the publication of the case.
DISCUSSION
Currently, some techniques such as the use of a dermatoscope and reflective
confocal microscopy are being highlighted as diagnostic advantages in the
context of BCC. This is because they provide visualization of characteristics
inherent to BCC, such as linear telangiectasias, arborizing veins, and nests
of
oval bluish-gray cells, in addition to pearly structures7,8. In the present case, as the main suspicion was
neoplasia based on vulvoscopy, it was decided to perform a punch biopsy. It
should be noted that the later the diagnosis, the greater the chances of
mutilating surgeries that compromise the patient’s quality of life.
Also according to validation in a series of recent cases, the site most affected
by BCC of the vulva is the labia majora, in around 90% of cases, and the average
age of affected women is 71.9 years, being the most affected ethnic group. the
Caucasian. As stated above, our patient is within the age range most frequently
affected by BCC of the vulva, and the affected site was considered the most
frequent in the literature (labia majora), although there are cases in which
the
lesion is located on the clitoris. , in the labia minora, in the perineum, and
the vaginal introitus1.
The initial symptoms may only be itching or nonspecific superficial lesions,
however, if not diagnosed and treated properly, they may progress to ulceration,
bleeding, and pain, since cancer in the vulva can have a more aggressive
behavior than in photo-exposed areas., with more perineural invasion and local
infiltration. It is worth noting that patients with basal cell nevus syndrome,
that is, a mutation in the PTCH gene, are more likely to
develop the disease and require regular skin exams as a follow-up.
As for types, the most common BCCs are nodular types, followed by superficial
ones. Generally, there is no need for a lymph node approach, as metastatic
involvement is rare. Inguinal lymphadenectomy is only indicated in the presence
of clinically evident lymph node metastasis. BCC is an entity that grows
indolently and has a low propensity to metastasize. Imaging studies are reserved
for advanced cases to evaluate the involvement of adjacent structures and help
with surgical planning8.
The diagnosis is made by biopsy with the aid of histopathological analysis using
hematoxylin and eosin dyes or the detection of typical markers by
immunohistochemistry, with CK20 being the most indicated, which was not
performed in our case due to the more morphological nature of the findings. ,
which can generate questions, and is mostly used for academic purposes. The
presentation can be confused with other diseases, such as psoriasis, dermatitis,
lichen sclerosus, vulvar intraepithelial neoplasia, and Paget’s
disease1,3.
Regarding the development of cancer, the p53 and
BCL2 genes are involved, participating in the regulation of
the cell cycle. The ki-67 and PCNA markers are linked to cancer predisposition.
Mutations in P53 can lead to the malignancy of pre-existing lesions and in BCL2
to the immortalization of the cell. As for the PCNA marker, it was not used in
our case because it is reserved for identifying injuries related to UV light,
with the present case being located in a non-photoexposed area. Ki-67 provides
prognostic information about the tumor and was not used in our case because it
is a non-ulcerated lesion with no signs of severity9.
Treatment can include topical application of 5% imiquimod, cryotherapy,
curettage, or wide local excision, also more recently including the Mohs
technique, with lower associated local recurrence rates, a problem better
related to location, and not to the size of the lesion.
It is worth noting that there are no guidelines that corroborate the superiority
of any technique in the treatment of these tumors and recurrence rates can reach
20%, although some authors suggest the surgical approach by excision with free
margins as effective. Systemic therapy can be recommended in cases of positive
margins, metastases, and advanced cases, with vismodegib being an excellent
option (HH signaling inhibitor)6,10.
CONCLUSION
The reported case of BCC of the vulva in a 63-year-old postmenopausal woman of
age with a history of vulvar injury following chronic inflammation of the
non-photo exposed site It is rare, and the treatment was carried out through
surgical resection of the tumor with margins. In 14 months of post-surgery
follow-up, the patient is without evidence of local or regional recurrence.
REFERENCES
1. Asilian A, Moeine R, Hafezi H, Shahriarirad R. Treatment of vulvar
basal cell carcinoma with Slow-Mohs micrographic surgery A case report. Clin
Case Rep. 2022;10(10):e6442.
2. Tan A, Bieber AK, Stein JA, Pomeranz MK. Diagnosis and management of
vulvar cancer: A review. J Am Acad Dermatol.
2019;81(6):1387-96.
3. Rudd JC, Li C, Hajiannasab R, Khandalavala J, Sharma P. Diagnosing
Basal Cell Carcinoma of the Vulva: A Case Report and Review of the Literature.
Cureus. 2021;13(12):e20791.
4. Renati S, Henderson C, Aluko A, Burgin S. Basal cell carcinoma of
the vulva: a case report and systematic review of the literature. Int J
Dermatol. 2019;58(8):892-902.
5. Kumar N, Ray MD, Sharma DN, Pandey R, Lata K, Mishra A, et al.
Vulvar cancer: surgical management and survival trends in a low resource
setting. J Egypt Natl Canc Inst. 2020;32(1):4.
6. Sinha K, Abdul-Wahab A, Calonje E, Craythorne E, Lewis FM. Basal
cell carcinoma of the vulva: treatment with Mohs micrographic surgery. Clin Exp
Dermatol. 2019;44(6):651-3.
7. Dalton AK, Wan KM, Gomes D, Wyatt JM, Oehler MK. Inguinal Metastasis
from Basal Cell Carcinoma of the Vulva. Case Rep Oncol.
2019;12(2):573-80.
8. Wohlmuth C, Wohlmuth-Wieser I. Vulvar malignancies: an
interdisciplinary perspective. J Dtsch Dermatol Ges.
2019;17(12):1257-76.
9. Flipo R, Bani MA, Rejaibi S, Talhi N, Sastre-Garau X. Vulvar Basal
Cell Carcinoma: Clinical and Histopathologic Features. Int J Gynecol Pathol.
2022;41(1):86-92.
10. Choi HY, Roh MS, Park JW. Vulvar Basal Cell Carcinoma in
Postmenopausal Women: Two Case Reports. J Menopausal Med.
2023;29(1):40-3.
1. Universidade Estadual do Piauí, Centro de
Ciências da Saúde, Teresina, Piauí, Brazil
2. Centro Universitário Uninovafapi, Teresina,
Piauí, Brazil
3. Medimagem, Teresina, Piauí,
Brazil
4. Oncocenter, Teresina, Piauí,
Brazil
Corresponding author: Rafael Everton Assunção Ribeiro da
Costa Rua Olavo Bilac 2335, Centro (Sul), Teresina, PI, Brazil. Zip
code: 64001-280, E-mail: rafaelearcosta@gmail.com